“Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s598. Accessed April 21, 2026. https://skin.dermsquared.com/skin/article/view/3844.